Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

View:
Post by 4Justice on May 07, 2020 2:20pm

Q1 2020

Is there someone who knows when Liminal will disclose his Q1 results ?

Remember that the numbers don't deceive and the market follows. No one, paid or not, can beat the numbers.
Comment by sah1 on May 07, 2020 2:23pm
Normally within 6 weeks after close of  quarter so sometime next week.
Comment by 4Justice on May 08, 2020 5:21pm
Thanks Sah You're the only one interested in my question. This is important and the results of Q1 will demonstrate Liminal's competence and vision. In fact we will be able to make a judgment on ken Galbraith works. he is the trusted man of the Thomson famely...FOR THE MOMENT !
Comment by aussyspitz on May 08, 2020 8:27pm
Typically companies will release bad news on Fridays after hours to soften the blow and good news early in the trading week pre-market to let it run.  So if I had to take a wild guess I would say they will release their Q1 ER on Friday May 22 after hours as that leads into the US Memorial Day weekend holiday. 
Comment by GoBBs on May 08, 2020 9:17pm
They have no recurring revenue to speak of, anything worthy would have come with a NR like a partnership, the sale of some other asset, the start of a placebo trial. I expect the sound of crickets with the highlight being the burn rate is down but still ridiculous...they will say we still have cash and the TV loan yet untouched but available. The only thing that matters is the BLA resubmission ...more  
Comment by sah1 on May 09, 2020 3:51pm
Justice, in addition to a corporate update on Ryplazim BLA and Alstrom trials, I am interested in seeing the cash burn for Q1 based on 300 employees and very limited R&D program.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities